Literature DB >> 11854475

Mortality in 7B2 null mice can be rescued by adrenalectomy: involvement of dopamine in ACTH hypersecretion.

V Laurent1, A Kimble, B Peng, P Zhu, J E Pintar, D F Steiner, I Lindberg.   

Abstract

The serine protease prohormone convertase 2 (PC2), principally involved in the processing of polypeptide hormone precursors in neuroendocrine tissues, requires interaction with the neuroendocrine protein 7B2 to generate an enzymatically active form. 7B2 null mice express no PC2 activity and release large quantities of uncleaved ACTH, resulting in a lethal endocrine condition that resembles pituitary Cushing's (Westphal, C. H., Muller, L., Zhou, A., Bonner-Weir, S., Schambelan, M., Steiner, D. F., Lindberg, I. & Leder, P. (1999) Cell 96, 689). Here, we have compared the 7B2 and PC2 null mouse models to determine why the 7B2 null, but not the PC2 null, exhibits a lethal disease state. Both 7B2 and PC2 nulls contained highly elevated pituitary adrenocorticotropic hormone (ACTH); the neurointermediate lobe content of ACTH in 7B2 nulls was 13-fold higher than in WT mice; that of the PC2 null was 65-fold higher. However, circulating ACTH levels were much higher in the 7B2 null than in the PC2 null. Because hypothalamic inhibitory dopaminergic control represents the major influence on intermediate lobe proopiomelanocortin-derived peptide secretion, dopamine levels were measured, and they revealed that 7B2 null pituitaries contained only one-fourth of WT pituitary dopamine. Adrenalectomized 7B2 null animals survived past the usual time of death at 5 weeks; a month after adrenalectomy, they exhibited normal levels of pituitary dopamine, circulating ACTH, and corticosterone. Elevated corticosterone, therefore, seems to play a central role in the lethal phenotype of the 7B2 null, whereas a 7B2-mediated dopaminergic deficiency state may be involved in the actual ACTH hypersecretion phenomenon. Interestingly, adrenalectomized 7B2 nulls also developed unexpectedly severe obesity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11854475      PMCID: PMC122477          DOI: 10.1073/pnas.261715099

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  59 in total

Review 1.  Proprotein and prohormone convertases: a family of subtilases generating diverse bioactive polypeptides.

Authors:  N G Seidah; M Chrétien
Journal:  Brain Res       Date:  1999-11-27       Impact factor: 3.252

2.  Mc3 and Mc4 receptors: complementary role in weight control.

Authors:  M L Raffin-Sanson; J Bertherat
Journal:  Eur J Endocrinol       Date:  2001-03       Impact factor: 6.664

3.  Influence of glucocorticoids on dopaminergic transmission in the rat dorsolateral striatum.

Authors:  M Barrot; D N Abrous; M Marinelli; F Rougé-Pont; M Le Moal; P V Piazza
Journal:  Eur J Neurosci       Date:  2001-02       Impact factor: 3.386

4.  Proceedings: In-vitro demonstration of melanocyte-stimulating hormone release inhibiting action of dopaminergic nerve fibres.

Authors:  F J Tilders; A H Mulder
Journal:  J Endocrinol       Date:  1975-03       Impact factor: 4.286

5.  Severe defect in proglucagon processing in islet A-cells of prohormone convertase 2 null mice.

Authors:  M Furuta; A Zhou; G Webb; R Carroll; M Ravazzola; L Orci; D F Steiner
Journal:  J Biol Chem       Date:  2001-05-16       Impact factor: 5.157

6.  Biogenic amines and control of melanophore stimulating hormone release.

Authors:  A Bower; M E Hadley; V J Hruby
Journal:  Science       Date:  1974-04-05       Impact factor: 47.728

7.  Complete remission of Nelson's syndrome after 1-year treatment with cabergoline.

Authors:  R Pivonello; A Faggiano; F Di Salle; M Filippella; G Lombardi; A Colao
Journal:  J Endocrinol Invest       Date:  1999-12       Impact factor: 4.256

Review 8.  Medical treatment of canine pituitary-dependent hyperadrenocorticism (Cushing's disease).

Authors:  M E Peterson
Journal:  Vet Clin North Am Small Anim Pract       Date:  2001-09       Impact factor: 2.093

9.  A unique metabolic syndrome causes obesity in the melanocortin-3 receptor-deficient mouse.

Authors:  A A Butler; R A Kesterson; K Khong; M J Cullen; M A Pelleymounter; J Dekoning; M Baetscher; R D Cone
Journal:  Endocrinology       Date:  2000-09       Impact factor: 4.736

10.  Impaired prohormone convertases in Cpe(fat)/Cpe(fat) mice.

Authors:  Y Berman; N Mzhavia; A Polonskaia; L A Devi
Journal:  J Biol Chem       Date:  2001-01-12       Impact factor: 5.157

View more
  19 in total

1.  Dynamic modulation of prohormone convertase 2 (PC2)-mediated precursor processing by 7B2 protein: preferential effect on glucagon synthesis.

Authors:  Michael Helwig; Sang-Nam Lee; Jae Ryoung Hwang; Akihiko Ozawa; Juan F Medrano; Iris Lindberg
Journal:  J Biol Chem       Date:  2011-10-19       Impact factor: 5.157

Review 2.  The extended granin family: structure, function, and biomedical implications.

Authors:  Alessandro Bartolomucci; Roberta Possenti; Sushil K Mahata; Reiner Fischer-Colbrie; Y Peng Loh; Stephen R J Salton
Journal:  Endocr Rev       Date:  2011-08-23       Impact factor: 19.871

3.  The propeptide precursor proSAAS is involved in fetal neuropeptide processing and body weight regulation.

Authors:  Daniel J Morgan; Suwen Wei; Ivone Gomes; Traci Czyzyk; Nino Mzhavia; Hui Pan; Lakshmi A Devi; Lloyd D Fricker; John E Pintar
Journal:  J Neurochem       Date:  2010-03-26       Impact factor: 5.372

Review 4.  POMC: The Physiological Power of Hormone Processing.

Authors:  Erika Harno; Thanuja Gali Ramamoorthy; Anthony P Coll; Anne White
Journal:  Physiol Rev       Date:  2018-10-01       Impact factor: 37.312

5.  Disruption of PC1/3 expression in mice causes dwarfism and multiple neuroendocrine peptide processing defects.

Authors:  Xiaorong Zhu; An Zhou; Arunangsu Dey; Christina Norrbom; Raymond Carroll; Chunling Zhang; Virginie Laurent; Iris Lindberg; Randi Ugleholdt; Jens J Holst; Donald F Steiner
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-26       Impact factor: 11.205

Review 6.  Regulation of the hypothalamic thyrotropin releasing hormone (TRH) neuron by neuronal and peripheral inputs.

Authors:  Eduardo A Nillni
Journal:  Front Neuroendocrinol       Date:  2010-01-13       Impact factor: 8.606

Review 7.  The chromogranins: their roles in secretion from neuroendocrine cells and as markers for neuroendocrine neoplasia.

Authors:  Steven A Feldman; Lee E Eiden
Journal:  Endocr Pathol       Date:  2003       Impact factor: 3.943

8.  Regulation of hypothalamic prohormone convertases 1 and 2 and effects on processing of prothyrotropin-releasing hormone.

Authors:  Vanesa C Sanchez; Jorge Goldstein; Ronald C Stuart; Virginia Hovanesian; Lihong Huo; Heike Munzberg; Theodore C Friedman; Christian Bjorbaek; Eduardo A Nillni
Journal:  J Clin Invest       Date:  2004-08       Impact factor: 14.808

9.  Dopamine-regulated adrenocorticotropic hormone secretion in lactating rats: functional plasticity of melanotropes.

Authors:  Márk Oláh; Pálma Fehér; Zsófia Ihm; Ildikó Bácskay; Timea Kiss; Marc E Freeman; Gyorgy M Nagy; Miklós Vecsernyés
Journal:  Neuroendocrinology       Date:  2009-07-30       Impact factor: 4.914

10.  Regulation of cell growth and expression of 7B2, PC2, and PC1/3 by TGFbeta 1 and sodium butyrate in a human pituitary cell line (HP75).

Authors:  Ikuo Kobayashi; Long Jin; Katharina H Ruebel; Jill M Bayliss; Oka Hidehiro; Ricardo V Lloyd
Journal:  Endocrine       Date:  2003-12       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.